---
title: Pneumatic Sleeves and Congestive Heart Failure
nct_id: NCT01691417
overall_status: COMPLETED
phase: NA
sponsor: Western Galilee Hospital-Nahariya
study_type: INTERVENTIONAL
primary_condition: Congestive Heart Failure
countries: Israel
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01691417.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01691417"
ct_last_update_post_date: 2012-09-24
last_seen_at: "2026-05-12T06:02:14.967Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Pneumatic Sleeves and Congestive Heart Failure

**Official Title:** The Impact of Intermittent Sequential Pneumatic Compression (ISPC) Leg Sleeves on Cardiac Performance in Patients With Congestive Heart Failure

**NCT ID:** [NCT01691417](https://clinicaltrials.gov/study/NCT01691417)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Lead Sponsor:** Western Galilee Hospital-Nahariya
- **Conditions:** Congestive Heart Failure
- **CT.gov Last Update:** 2012-09-24

## Brief Summary

Based on the reversal of the adverse cardiovascular parameters during Laproscopic Surgery and its influence on cardiac activity in healthy subjects, the investigators expect to improved cardiac function in patients suffering from congestive heart failure.

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* CHF (as clinically evaluated and asessed by TTE)
* Gave informed consent
* NYHA Class II-III
* LVEF equal or less than 40%

Exclusion Criteria:

* Patients who could not sign informed consent
* NYHA Class IV
* Oxygen saturation less than 90% under room air
```

## Arms

- **Pneumatic Sleeves** (EXPERIMENTAL)
- **Congestive Heart Failure Patients** (EXPERIMENTAL)

## Interventions

- **Intermittent Sequntial Pnumatic Compression Leg Sleeves** (DEVICE)

## Primary Outcomes

- **Cardiac Output**

## Secondary Outcomes

- **Systemic vascular resistance**

## Locations (1)

- Western Galilee Hospital, Nahariya, Israel

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.western galilee hospital|nahariya||israel` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01691417.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01691417*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*